
Metabolism & Fat Loss
CagriSema (Cagrilintide + Semaglutide)
CagriSema is a fixed-ratio co-formulation of cagrilintide (amylin analogue) and semaglutide (GLP-1 agonist). Research has demonstrated additive mechanisms producing greater weight loss than either compound alone. Dual neurohormonal targeting reduces caloric intake via complementary satiety pathways. For research use only.
MOLECULAR FORMULA
Combination peptide
MOLECULAR WEIGHT
Combined ~7500 g/mol
STORAGE
Store lyophilised at -20°C.
SELECT VARIANT
INCLUDED WITH EVERY VIAL — Professionally Boxed
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.
QUALITY VERIFICATION
Verify Your Batch
Verify Your Batch
Enter the batch number from your vial to instantly access the Certificate of Analysis.
DOCUMENTATION
Certificates of Analysis
BATCH 3739
EXP: 2027-05-22
